<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03925025</url>
  </required_header>
  <id_info>
    <org_study_id>AC19003</org_study_id>
    <nct_id>NCT03925025</nct_id>
  </id_info>
  <brief_title>Effectiveness of Calcium Channel Blockade for OP and Carbamate Pesticide Poisoning</brief_title>
  <acronym>CCBOC</acronym>
  <official_title>Effectiveness of Calcium Channel Blockade for Organophosphorus and Carbamate Pesticide Poisoning - an Open, Pragmatic, 3-arm RCT Repurposing Two Widely Available Licensed Medicines</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Edinburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Toxicology Society of Bangladesh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Edinburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates whether the addition of intravenous magnesium sulphate or nimodipine to
      standard therapy (supportive care plus for all patients atropine and, for OP insecticide
      poisoned patients, pralidoxime) benefits patients after acute anticholinesterase
      self-poisoning with OP or carbamate insecticides.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2020</start_date>
  <completion_date type="Anticipated">June 2024</completion_date>
  <primary_completion_date type="Anticipated">June 2024</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>through to hospital discharge, median 1 week</time_frame>
    <description>Whether dead or alive at hospital discharge</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">3100</enrollment>
  <condition>Anticholinesterase Insecticide Poisoning</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Magnesium sulfate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard therapy plus magnesium sulfate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nimodipine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard therapy plus nimodipine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium Sulfate</intervention_name>
    <description>Treatment in addition to standard therapy</description>
    <arm_group_label>Magnesium sulfate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nimodipine</intervention_name>
    <description>Treatment in addition to standard therapy</description>
    <arm_group_label>Nimodipine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged 16 years or older with suspected OP or carbamate insecticide
             self-poisoning admitted to medical wards with the cholinergic toxidrome requiring
             atropine.

          -  Diagnosis will be made on the basis of the cholinergic toxidrome clinical features
             (eg. small/pinpoint pupils, bronchorrhoea, sweating) or on the history of atropine
             administration with beneficial effect. The insecticide involved will be identified
             where possible from the history, the bottle brought in by the patient or relative, the
             patient/relative identifying the pesticide on a chart showing all locally available
             pesticides, and/or relatives sending a photo of the bottle by eg. WhatsApp.

          -  Patients who ingest combination products containing OP or carbamate insecticides will
             also be included.

          -  Inhibited blood cholinesterase activity as shown by routine clinical bedside test

        Exclusion Criteria:

          -  Children aged &lt;16 years.

          -  Patients who do not require atropine and have not had it prior to presentation during
             this episode.

          -  Normal blood cholinesterase activity

          -  Self-reported known pregnancy (as per South Asian practice, no attempt will be made to
             formally test for pregnancy in the patients due to the issue of confidentiality in the
             acute care situation in these hospitals and the social consequences of an unexpected
             positive response)

          -  Known occupational and homicidal poisoning

          -  Past medical history of severely impaired renal function

          -  Hypersensitivity to magnesium and its salts

          -  Patients who have had a myocardial infarction or unstable angina in the last month

          -  Patients with traumatic subarachnoid haemorrhage

          -  Lack of informed consent (unaccompanied unconscious patients and others)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michael Eddleston, ScD</last_name>
    <phone>01312426776</phone>
    <email>m.eddleston@ed.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rabbi Chowdhury, MD</last_name>
    <email>mastershakil@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chittagong Medical College</name>
      <address>
        <city>Chittagong</city>
        <country>Bangladesh</country>
      </address>
    </facility>
    <contact>
      <last_name>Aniruddha Ghose, MD</last_name>
      <phone>+8801711068841</phone>
      <email>anrdghs@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Bangladesh</country>
  </location_countries>
  <reference>
    <citation>Brvar M, Chan MY, Dawson AH, Ribchester RR, Eddleston M. Magnesium sulfate and calcium channel blocking drugs as antidotes for acute organophosphorus insecticide poisoning - a systematic review and meta-analysis. Clin Toxicol (Phila). 2018 Aug;56(8):725-736. doi: 10.1080/15563650.2018.1446532. Epub 2018 Mar 20.</citation>
    <PMID>29557685</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 17, 2019</study_first_submitted>
  <study_first_submitted_qc>April 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2019</study_first_posted>
  <last_update_submitted>May 22, 2020</last_update_submitted>
  <last_update_submitted_qc>May 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Poisoning</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Magnesium Sulfate</mesh_term>
    <mesh_term>Nimodipine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Six months after primary data analysis is published</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

